Halofuginone for non-hospitalized adult patients with COVID-19 a multicenter, randomized placebo-controlled phase 2 trial. The HALOS trial by Tomazini, Bruno Martins, Tramujas, Lucas, Medrado, Junior, Fernando Azevedo, Gomes, Samara Pinheiro do Carmo, Negrelli, Karina Leal, Murinize, Gabriela Souza, Santos, Renato Hideo Nakagawa, Vianna, Bruna Martins Pereira, Piotto, Bruna Fornazieri, Veiga, Thabata Silva, Santos, Bianca Rodrigues do, Peneluppi Horak, Ana Clara, Lemos, Olivia Mora Cavalcante, Lopes, Marcela de Almeida, Olicheski, Beatriz Baptista, Campones, Diego Lurentt, Peixoto, Luiz Angelo Alencar, Basilio, Aline Dos Anjos Chaves, Gebara, Otavio Celso Eluf, Lopes, Ana Tarina Alvarez, Saconato, Humberto, Valeis, Nanci, Miranda, Tamiris Abait, Laranjeira, Ligia Nasi, Santucci, Eliana Vieira, Carlin, Aaron Foster, Esko, Jeffrey David, Gordts, Phillip Leo Stephan Marie, Tsimikas, Sotirios, Cavalcanti, Alexandre Biasi

Get full text